Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Double Blind, Multicenter Study for Hyalobarrier ® to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG® After Thyroidectomy

NCT01696305 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01696305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01696305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Double Blind, Multicenter Study for Hyalobarrier ® to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG® After Thyroidectomy
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2012
Completion date
February 28, 2014
Enrollment
198 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid disease